INTELLIGENT BIO SOLUTIONS IN (INBS) Stock Income Statement
NASDAQ:INBS - Nasdaq - US36151G6008 - Common Stock - Currency: USD
| TTM (2024-12-31) | 2024 (2024-6-30) | 2023 (2023-6-30) | 2022 (2022-6-30) | 2021 (2021-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 3.03M | 3.11M | 1.26M | 437.20K | 1.98M | |||
| Minority Interest Expense | 36.70K | 34.20K | 32.80K | 27.90K | 22.90K | |||
| Cost Of Goods | 1.47M | 1.69M | 930.20K | N/A | N/A | |||
| Gross Profit | 1.56M | 1.43M | 326.70K | N/A | N/A | |||
| Operating Expenses | 12.32M | 11.71M | 8.76M | 8.77M | 7.19M | |||
| Research and Development | 2.68M | 1.67M | 507.40K | 3.85M | 3.84M | |||
| Selling, General, and Administrative Expenses | 8.85M | 9.26M | 8.03M | 4.92M | 3.36M | |||
| Operating Income | -10.76M | -10.28M | -8.44M | -8.34M | -5.21M | |||
| Interest Income/Expense | 21.60K | 92.20K | 1.93M | 2.90K | -1.49M | |||
| Non Recurring Items | N/A | 0.00 | -4.16M | 0.00 | -359.20K | |||
| Income Before Taxes | -10.73M | -10.19M | -10.66M | -8.33M | -7.06M | |||
| Income Tax | N/A | N/A | N/A | N/A | 0.00 | |||
| Net Income | -10.70M | -10.16M | -10.63M | -8.31M | -7.04M | |||
| EBITDA | -9.77M | -9.31M | -7.62M | N/A | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -3.55 | -6.38 | -127.02 | -135.94 | -162.14 | |||
| Statistics | ||||||||
| Gross Profit Margin | 51.59% | 45.81% | 25.99% | N/A | N/A | |||
| Profit Margin | -352.88% | -326.40% | -845.87% | -1899.84% | -355.33% | |||
| Operating Profit Margin | -354.79% | -330.46% | -671.21% | -1906.88% | -263.28% | |||
All data in USD